Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

1.68

Today's Change

+0.035 (2.12%)

Day's Change

1.65 - 1.75

Trading Volume

3,979,626

Overview

Market Cap

414 Million

Shares Outstanding

246 Million

Avg Volume

4,571,139

Avg Price (50 Days)

2.14

Avg Price (200 Days)

1.68

PE Ratio

-2.11

EPS

-0.80

Earnings Announcement

02-May-2024

Previous Close

1.65

Open

1.73

Day's Range

1.65 - 1.75

Year Range

0.92 - 3.79

Trading Volume

3,982,851

Price Change Highlight

1 Day Change

2.12%

5 Day Change

8.71%

1 Month Change

-23.76%

3 Month Change

-20.89%

6 Month Change

20.36%

Ytd Change

5.97%

1 Year Change

-29.20%

3 Year Change

-65.19%

5 Year Change

-72.24%

10 Year Change

-84.27%

Max Change

-98.72%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment